The inaugural E-Cigarette Summit was held at the Royal Society, London, in November 2013 and came at a critical point in history when both public health experts and regulators were negotiating the TPD (European Tobacco Products Directive) and grappling to understand a consumer driven product that was on an unprecedented growth trajectory.
Now moving into its 11th year in the UK and 8th year in Washington D.C, The E-Cigarette Summit has gained an unparalleled reputation as a neutral meeting point for scientists, regulators, industry, public health and practitioners to explore the latest research on e-cigarettes and facilitate respectful debate on what remain highly controversial issues. The aim will always be to ensure that disparate views can be explored in context of a common aim, which is to reduce smoking related death and disease.
The Summit is planned as an in-person event for speakers but we aim to maximise the experience for all delegates, whether you are joining us in person, watching the live stream virtually or catching up later on-demand. All Summit participants will have access to the event app where they can view the Speaker slides, follow the active chat/ discussion and submit questions for the panel debates.
We will “live stream” the Summit as per the Agenda (UK Time zone). Individual videos of speaker presentations and the panel discussions will be added to the virtual platform within 24 hours of the live event for you to watch/re-watch later. The app will be live for 3 months after the event.
The app will allow you to:
- View presentation PPT slides
- Join in the on-line conversation with all delegates – including those that are virtual
- Participate in Polls
- Submit/answer questions and upvote questions for the panels
- Share thoughts, photos and suggestions
- Access videos of the presentations after the event for 3 months.
Science & Evidence
- OPENING KEYNOTE: Are we scapegoating young people and where should collective responsibility lie?
- Complex problems, clumsy solutions and the court of public opinion
- Do e-cigarettes increase youth smoking? The current state of evidence on gateway
- Is vaping an effective and safe aid for quitting smoking? The Cochrane review of electronic cigarettes for smoking cessation
- Why do countries have different policies on e-cigarettes?
- The UK’s strategy to end smoking
Regulation & Research
- Disposable vapes in Great Britain: Impact and Implications
- Packaging policy to reduce youth e-cigarette use
- Risk perceptions of e-cigarettes
- Restricting flavoured e-cigarette sales: Policy effects & alternatives
- Harm reduction beyond e-cigarettes: how do heated tobacco products compare?
- Why is the MHRA E-cigarette notification scheme essential for the short and long-term protection of public health?
THR, Nicotine & Smoking
- Swap to Stop – Going for a million
- Opportunities and dilemmas- how Fresh is addressing vaping within a collective shared vision for a Smokefree Future
- The North East North Cumbria’s approach to vaping and a respiratory clinician’s perspective
- Implementation of a Generation End Game (GEG) in Malaysia : Evolution in tobacco policies
- How vaping has become mainstream
Tobacco Policy & End Game Strategies
- E-cigarettes and tobacco control in Great Britain: Where are we now and why
- The smoking endgame and youth vaping in New Zealand
- Tobacco Harm Reduction: too serious a matter to be left to the tobacco industry
- The end of what?
- Tobacco Harm Reduction in Southeast Asia-Challenges and Opportunities
- CLOSING KEYNOTE: Keeping our eyes on the prize in nicotine and tobacco policy
Professor of Respiratory Science, Institute of Lung Health
University Hospitals of Leicester NHS Trust, Special Advisor on Tobacco, Royal College of Physicians
Action on Smoking and Health
Counterfactual Consulting Ltd
Professor of History and Health Policy, Centre for History in Public Health
London School of Hygiene & Tropical Medicine, London, UK
Deputy Chief Executive & Policy Director
ASH (Action on Smoking & Health)
Head of E-Cigarettes, Healthcare, Quality and Access Group
MHRA - The Medicines and Healthcare products Regulatory Agency
Tobacco Control Programme Lead
Office of Health Improvement & Disparities (OHID)
Professor of Hospital Management and Health Economics and Deputy Dean (Relation & Wealth Creation)
Faculty of Medicine, UKM Medical Centre
Department of Health Policy & Management
Yale School of Public Health
Director of the Health and Lifestyle Research Unit
Wolfson Institute of Population Health, Queen Mary University of London
Assistant Professor in Health Promotion and Policy
University of Massachusetts Amherst
Principal Research Fellow Behavioural Science and Health
University College London (UCL)
Smokefree NHS Strategic Manager
North East and North Cumbria ICB
Professor of Tobacco Addiction
Institute of Psychiatry, Psychology & Neuroscience, King's College London
Director of Public Health Analysis
Office for Health Improvement and Disparities (OHID)
Chair of Addiction Sciences
University of East Anglia
Former Director, Research, Policy & Cooperation, World Health Organization
Clinical Consultant, NCSCT
Chair and Mental Health Lead, New Nicotine Alliance
Fresh and Balance
Professor of Health Psychology, University College London
Co-Director of the UCL Tobacco and Alcohol Research Group
Clinical Lead for Tobacco Dependency for the North East & North Cumbria ICS
Respiratory Consultant, Queen Elizabeth Hospital - Gateshead
University College London (UCL)
PHD Student and Research Assistant - Nicotine Research Group
King's College London (KCL)
Professor Emeritus of Health Psychology
University College London
ASH New Zealand